Micro Chemicals
Market Cap
₹1,149 ₹1,149 Cr.
P/E
16.10
PEG
1.16
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes alive if Performance Solutions converts added capacity, biocide expansion and contract-manufacturing opportunities into recurring sales, supported by improving utilization.

The bull path requires above-plan Performance Solutions utilization alongside contract-manufacturing supplies and biocide commercialization, while the bear path reflects weak agrochemical demand and delayed customer conversion.

Key Ratios

Debt to Equity
Debt to Equity
0.00
Div Yield (%)
Div Yield (%)
1.50
Individual < 2 lac
Individual < 2 lac
24.77 %
Institutions
Institutions
8.67 %
Market cap
Market cap
1,149 Cr
No. of Shareholders
No. of Shareholders
21,439
OPM (%)
OPM (%)
10.20 %
PE
PE
16.10
Prom Holding
Prom Holding
51.86 %
ROCE (%)
ROCE (%)
5.42
ROE (%)
ROE (%)
4.44
Sales
Sales
1,078 Cr
  • Excel Industries
  • Punjab Chem. & Corp.
  • Meghmani Organics
  • TJI Chemicals
Last updated on 25 Sep 2026
  • Excel Industries makes agrochemical intermediates, specialty chemicals, polymer inputs and pharma and veterinary products. It reports as a single chemicals segment.
  • It sells to agrochemical, specialty, polymer and pharma customers, including MNC contract customers. About 80% of FY26 revenue was domestic and 20% was export.
  • Profit comes mainly from agrochemical intermediates at about 62% of revenue. Specialty and polymer inputs add the rest. Agro demand and raw-material costs drive volatility.
  • Per annual reports, it is the world No.1 in a principal product and top-five in phosphonate chemicals. It is backward integrated in phosphorus chemistry.
  • It is shifting mix away from agro toward performance solutions and contract manufacturing. Specialty and import-substitute biocide capacity is under execution.
  • Q1FY27 revenue fell 5% but EBITDA margin recovered to 14.4% on mix. PAT fell on lower other income. The contract line was commissioned on time.
  • It has no long-term debt and funds capex with accruals and a customer advance. Receivables are 87 days, up from 62 days in FY22.
  • It is mid-pivot from agro cyclicality to contracted growth. Near-term profit depends on ramping contract and specialty volumes. Management guides Rs.200-300Cr capex over 2-3 years.
  • It remains exposed to agrochemical cycles. Input costs and monsoon-linked inventory swings drive margins.
  • Import-substitute biocide launch H2FY27
    the new import-substitute biocide comes online.
  • Specialty line at Lote Feb 2027
    the line adds 1,265 MTPA of specialty capacity for Rs.5Cr.
  • Dedicated contract line ramp 12-18 month ramp, peak into FY28
    the line is guided to add Rs.35-40Cr a year excluding raw materials. The customer supplies raw materials.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
800
52W Range
High
1168
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

60 %
(as of Mar 19)
DETC - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Excel Industries Ltd. Business

Excel Industries Ltd is a chemical manufacturing company specializing in agrochemical intermediates, phosphates, specialty chemicals, and pharma products. They also convert Municipal Solid Waste into Organic Soil Conditioner.

Excel Industries major competitors are Punjab Chem. & Corp., Meghmani Organics, Dharmaj Crop Guard, India Pesticides, The Yamuna Syndicate, Astec Lifesciences, Transpek Industry.
Market Cap of Excel Industries is ₹1,162 Crs.
While the median market cap of its peers are ₹1,275 Crs.

Excel Industries seems to be less financially stable compared to its competitors.
Altman Z score of Excel Industries is 3.65 and is ranked 6 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Feb May Aug May Aug Nov Feb Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
Conference Call May Mar Nov
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material